Liz joined the team at 272BIO Limited as Operations Director in 2019. Liz has 26 years leadership experience in the Pharma/Biotech Industry.
In 1996 Liz joined the Pfizer Animal Health Group in Sandwich as a team leader in in vitro pharmacology, working across multiple therapeutic areas. Liz held positions of increasing responsibility over the subsequent 11 years, as Project Leader, Head of In vitro Sciences and Lead Discovery. Liz then took up a role as Research Program Manager within Pfizer R&D at Sandwich with responsibility for the planning and operational progression and budgetary management of all R&D projects within the Pain portfolio. Latterly, Liz was appointed as Scientific Development Officer, with a diverse remit, working with the Head of the Sandwich site to align the financial and scientific needs of the organization and shape the R&D portfolio. In 2011 Liz became a Founder and Chief Operating Officer of a clinical stage biotech company, raising over $26MM in funding, and has taken this company through Ph IIB clinical trials.
Our Management Team leverages their deep industry experience, data-driven insights and strategic innovation to empower our team of advocates who deliver novel healthcare solutions that help customers succeed in an increasingly challenging business climate.